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Using low molecular weight chitosan nanoparticles (CNPs) prepared by an ionic gelation 
method, we report the effect of low-intensity pulsed ultrasound (US) on cell viability and 
nanoparticle uptake in cultured murine pre-osteoblasts. Particle size and zeta potential are 
measured using Dynamic Light Scattering (DLS), and cell viability is evaluated using the 
MTS assay. Results show that 30 min delivery of CNPs at 0.5 mg/mL is able to prevent 
loss of cell viability due to either serum starvation or subsequent exposure to US (1 
W/cm2 or 2 W/cm2, up to 1 min). Additionally, flow cytometry data suggest that there is 
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a close association between cellular membrane integrity and the presence of CNPs when 
US at 2 W/cm2 is administered. 
 
I. INTRODUCTION 
A linear polysaccharide derived from the exoskeleton of crustaceans, cell walls of 
fungi and cocoons of insects,1 chitosan is a low-immunogenic cationic polymer that can 
form solid colloidal nanoparticles in the range of 1 nm to 1000 nm.2  Chitosan-based 
nanoparticles (CNPs) are highly biocompatible 3-6 and respond to external stimuli such as 
ultrasound (US).7,8 Because US irradiation is widely used in clinical diagnostics as well 
as for wound healing and cancer therapy,9-11 polymers that are capable of undergoing 
sonolytic degradation are of great biomedical importance. 
US is composed of a propagating pressure wave or sound wave, which can help 
transfer mechanical energy into various tissues of the body.12 The frequency, duty cycle 
and duration all contribute toward the total absorbance of energy. US has been found to 
enhance bone fracture healing13 as well as aid in drug release.14 Low-intensity US in 
particular can enhance the delivery efficiency of drug carriers such as polyethylene glycol 
(PEG), liposomes and micelles, thereby increasing the therapeutic efficacy of the 
cargo.15-18 For example, US (0.3 W/cm2) has been shown to significantly increase the 
anticancer effect of doxorubicin (DOX) in human bladder carcinoma cells.19 Exposure to 
US at 1 MHz (0.2-0.5 W/cm2) for 60 s was also shown to increase sensitivity to 
doxorubicin in DOX-resistant human uterine sarcoma cells.20 As such, US-mediated 
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delivery of nanotherapeutics may help reverse multidrug-resistance of certain cancer 
cells.21,22  
Although low-intensity US has been shown to be effective in assisting drug delivery 
from polymer-based vehicles, there is little documentation regarding the viability of the 
healthy tissue at the irradiation site. The primary objective of this work therefore is to 
examine the effect of ultrasound-assisted delivery of chitosan nanoparticles (CNPs) in a 
mammalian cell line by investigating cell viability and uptake. A more complete 
understanding of non-invasive sonodynamic therapy can help evaluate its efficacy as a 
potential adjuvant to conventional drug delivery. 
 
II. EXPERIMENTAL 
A. Materials 
Low molecular weight chitosan (deacetylation degree 75%-85%), sodium 
tripolyphosphate (TPP, technical grade, 85%), 2% ninhydrin reagent solution (ninhydrin 
and hydrindantin in DMSO and lithium acetate buffer, pH=5.2), and fluorescein 5(6)-
isothiocyanate were purchased from Sigma-Aldrich (St. Louis, MO). Sodium hydroxide 
pellets (reagent grade, 98.8%), formaldehyde solution (Reagent A.C.S, 37%) and 
glacial acetic acid (analytical grade, 99.9%) were obtained from J.T. Baker (Center 
Valley, PA). Methanol (Reagent A.C.S, 99.9%) and water (HPLC grade) were 
purchased from Pharmco-AAPER (Brookfield, CT). D-(+)-Trehalose dihydrate (99%) 
was obtained from Acros Organics (NJ, USA) and dialysis cassettes (3500 MWCO) were 
purchased from Thermo Scientific (Rockford, IL). 
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B. Synthesis 
1. Chitosan-TPP nanoparticles 
An ionic gelation method was used to synthesize the chitosan nanoparticles, 
similar to previous reports.2,23 Low molecular weight chitosan was dissolved in acetic 
acid (1% v/v, in water) for 30 min under constant stirring to make a 0.5% (w/v) chitosan 
stock solution, which was filtrated with a 0.8 µm syringe filter before gelation. A few 
drops of sodium hydroxide were added to the chitosan stock solution to adjust the pH 
value to 4.6-4.8. Tripolyphosphate (TPP) solution (0.25% w/v, in water) was added 
dropwise into the chitosan solution until opalescent droplets could be seen. After 5 min of 
reaction, the nanoparticle solution was centrifuged at 2700 RPM for 30 min and rinsed 
extensively with DI water. D-(+)-Trehalose was added to nanoparticle solution to a final 
concentration of 5% (w/v). The nanoparticles were stored in a -80°C freezer for at least 
24 h and lyophilized. To prepare FITC-labeled CNP (FITC-CNP), FITC-conjugated 
chitosan was first prepared using published protocols.24 The same ionic gelation method 
was conducted in the dark. 
C. Characterization 
1. FITC labeling efficiency 
In order to calculate the labeling efficiency of FITC, a standard curve plotting 
absorbance vs. FITC concentration was used. FITC standard solutions ranging from 0.01 
µg/mL to 0.08 µg/mL were prepared by diluting 100 µg/mL FITC stock solutions (in 
methanol) with 1x phosphate-buffered saline (PBS). An FITC-chitosan test sample was 
prepared by dissolving FITC-chitosan in 0.1 M acetic acid followed by dilution with 
PBS, until a final concentration of 1.0 µg/mL was achieved. All solutions were evaluated 
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in triplicate by ultraviolet-visible spectroscopy (Perkin Elmer Lambda 950, Perkin Elmer, 
Waltham, MA). FITC labeling efficiency was calculated using the equation below: 
 
%100
chitosan of weight - FITC ofweight 
FITC ofweight efficiency labeling FITC 
  (1) 
 
2. Particle size and zeta potential 
Measurements of particle size and surface charge (characterized as zeta potential) 
were performed by dynamic light scattering (DLS), using a ZEN3600 Nano Zetasizer 
(Malvern Instruments, UK) located at the Center for Functional Nanomaterials (CFN) of 
Brookhaven National Laboratory (Upton, NY).  Freeze-dried chitosan nanoparticles 
prepared at 6:1 chitosan:TPP mass ratio were dissolved in DI water to make a 1 mg/mL 
CNP suspension. In order to remove large aggregates, the suspension was then passed 
through a 0.8 µm syringe filter, and the filtrate was collected and stored at 4°C prior to 
analysis. The particle size measurements were conducted at room temperature and each 
measurement lasted for 120 s. For zeta potential measurement, a specific zeta dip cell was 
used and 30 measurements were collected for each sample. All measurements were 
performed at 25°C in triplicate. 
 
D. Nanoparticle delivery and ultrasound irradiation 
MC3T3-E1 murine pre-osteoblasts (subclone 4; American Type Culture Collection, 
Manassas, VA) were maintained in -modified minimum essential medium (-MEM; 
Gibco, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS) and 1% 
 6
penicillin-streptomycin (pen-strep) solution. The cells were maintained at 37°C in an 
atmosphere of 5% carbon dioxide and 95% relative humidity.  
Twenty-four hours prior to the delivery of chitosan-TPP nanoparticles, MC3T3-E1 
cells were seeded onto a 96-well tissue culture plate at 10,000 cells/cm2 (for viability 
assay), a 24-well tissue culture plate at 5,000 cells/cm2 (for confocal microscopy), or a 35 
mm (diam.) tissue culture plate at 50,000 cells/cm2 (for flow cytometry). Cells were 
incubated for 24 h in a humidified incubator (5% CO2) to attach completely. The 
supernatant was aspirated and the cells were washed with PBS. Fresh complete medium 
(supplemented with FBS) or serum-free medium containing either 0 or 0.5 mg/mL CNPs 
was added. The plates were gently swirled before being returned to the incubator. After 
30 min, cells that were to receive ultrasound (US) treatment were removed from the 
incubator and immediately sonicated by a Sonicator 740 (Mettler Electronic Corp. 
Anaheim, CA) with a 1 MHz applicator and 5 cm2 probe (Fig. 1). US intensity was set at 
either 1 W/cm2 or 2 W/cm2, for a total exposure time of either 30 s or 60 s. Cells that 
were not treated with US were kept on the lab bench for the same amount of time. All 
cells were then returned to the incubator for an additional 90 minutes. 
 
E. Cell viability 
Cytotoxic effect of ultrasound and CNP was examined using the MTS viability 
assay. Aliquots of MTS/PMS solution were added to the supernatant in each cell culture 
well, and the tissue culture plate was swirled gently before being incubated for 1 h at 
37°C. Absorbance was immediately read at 490 nm using a microplate reader (BioTek 
FLx800; BioTek, Winooski, VT). 
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F. Confocal microscopy 
Cells were fixed with 3.7% formaldehyde (in PBS) for 15 min, followed by 
extensive rinsing with PBS and immersion in 2.5 µg/mL DAPI solution for 5 min. After 
removal of the DAPI solution, the cells were rinsed two more time with PBS. 
Fluorescence micrographs were then captured using a DSU confocal microscope 
(Olympus IX2-DSU) and Z-scans were obtained with a total scan depth of 5.8 µm, with a 
0.2 µm step size. 
 
G. Flow cytometry 
Cells that were exposed to 2 W/cm2 US for 60 s were detached from the tissue 
culture plate with 0.05% Trypsin-EDTA and resuspended in 1 mL complete medium. 
Propidium iodide (10 µg/mL in PBS) was applied for 1 min at 4°C in the dark. Samples 
were immediately read by a FACS Calibur flow cytometer (BD Biosciences) using a 488 
nm laser. 
 
III. RESULTS AND DISCUSSION 
A. Physicochemical Properties of Chitosan-TPP Nanoparticles 
The FITC labeling efficiency of FITC-chitosan calculated using Equation (1) was 
2.4%, which is similar to previous reported value of 2.7%.25 Average particle size of 
freeze dried CNPs and FITC-CNPs re-suspended in water was 288.4  1.2 nm and 294.0 
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 10.8 nm, respectively. Average zeta potential of CNP and FITC-CNP in water was 
36.87 0 .27 mV and 32.90  0.64 mV, respectively. 
B. In Vitro Uptake of FITC-labeled Chitosan-TPP Nanoparticles  
Confocal micrographs showed greater internalization of the FITC-CNP by the 
MC3T3-E1 cells under US exposure compared to the non-irradiated cells (Fig. 2). 
Aggregates of FITC-CNP appeared larger in cells that were treated for either 30 seconds 
at 1 W/cm2 or 60 s at 2 W/cm2. 
C. Cell Viability 
Results from the MTS viability assay showed that when the untreated control 
MC3T3-E1 cells were cultured in complete medium (“CM” group, Fig. 3) without 
exposure to either US or CNP, cell density after 2 h of attachment reached the seeding 
density of 10,000 cells/cm2 (Fig. 3), indicating 100% viability. Application of US at 
either 1 or 2 W/cm2 for a minimum of 30 s to cells maintained in complete medium 
significantly decreased cell density by ~20% (p < 0.001; Fig. 3). There was no significant 
difference among the US treatments. When cells were temporarily serum-starved but not 
exposed to CNP (“SS” group, Fig. 3), cell density at 2 h dropped to 6600-6800 cells/cm2 
for all samples irrespective of US treatment, corresponding to a 32-34% reduction 
relative to untreated controls (p < 0.001). Interestingly, when CNPs were added during 
the 2 h serum starvation period (“SS+CNP” group, Fig. 3), cells appeared to be more 
viable compared to those that were serum-starved for the same duration in the absence of 
CNP. More specifically, area densities of cells were not significantly different between 
the untreated controls and those exposed simultaneously to CNP and either lower 
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intensity US (1 W/cm2) or no US at all (p > 0.2; Fig. 3). At the higher US intensity of 2 
W/cm2, cell density decreased significantly by 8% after 30 s of exposure (p < 0.001) and 
13% after 60 s of exposure (p < 0.01). 
D. Flow Cytometry 
To further investigate the significant decrease in cell viability after the MC3T3-E1 
cells were exposed to 60 s of US at 2 W/cm2, we conducted flow cytometry 
measurements following the addition of propidium iodide (PI) to the treated cells. Scatter 
plots indicated that US alone did not have an effect on the cells’ ability to uptake PI (Fig. 
4 a-b and e-f), which suggests that cellular membrane was not damaged by US, even 
though metabolic activity was decreased as seen from the MTS data (Fig. 3). When CNPs 
were delivered alone in the absence of US stimulation, FITC fluorescence was notably 
stronger, as shown by the dense scatter in the lower-right quadrant (Fig. 4 c and g). This 
suggests that CNPs had a great affinity for the MC3T3-E1 cells. We also observed that 
uptake of PI was diminished in this case, as seen by an absence of dense clusters in the 
upper-left quadrant of the scatter plot (Fig. 4 c and g) compared to either untreated cells 
(Fig. 4 a and e) or those exposed to US alone (Fig. 4 b and f). This indicates that CNPs 
may have protected the cell membrane from being damaged during sample preparation. 
When US was applied immediately after CNP delivery, FITC fluorescence was even 
more greatly enhanced (lower-right quadrant, Fig. 4 d and h), indicating that more CNPs 
were associated with, and possibly internalized by, the MC3T3-E1 cells. In addition, PI 
fluorescence was also enhanced (upper-right quadrant, Fig. 4 d and h), which suggests 
that cellular membrane may have become less intact. Moreover, because the population 
of cells with strong PI fluorescence overlapped those with strong FITC fluorescence (Fig. 
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4 d and h), we believe that membrane leakiness may be associated with the presence of 
CNPs. 
 
 
IV. SUMMARY AND CONCLUSIONS 
In this study, chitosan/TPP (CNP) and FITC-labeled chitosan/TPP nanoparticles 
(FITC-CNP) were successfully formulated by a modified ionic gelation method. FITC-
CNPs were delivered to murine pre-osteoblasts (MC3T3-E1 cell line, subclone 4), and 
the uptake was shown to be enhanced by ultrasound (US) irradiation. Serum starvation 
for 2 h resulted in a 32-34% reduction in cell viability, which was not observed when 
CNPs were administered simultaneously. The same phenomenon was observed when 
low-intensity US treatment (1 W/cm2) was applied during serum starvation, but at higher 
intensity (2 W/cm2) cell viability was notably decreased. Additionally, there seems to be 
a close association between ultrasound-assisted CNP delivery and membrane integrity. 
Taken together, these results suggest that CNPs may alter the sensitivity of pre-
osteoblasts to therapeutic levels of low-intensity pulsed ultrasound. 
 
ACKNOWLEDGMENTS 
Research was carried out in part at the Center for Functional Nanomaterials, Brookhaven 
National Laboratory, which is supported by the U.S. Department of Energy, Office of 
Basic Energy Sciences, under Contract No. DE-AC02-98CH10886. 
 
 11
 
 
1M. Kumar, R. A. A. Muzzarelli, C. Muzzarelli, H. Sashiwa, and A. J. Domb, Chemical 
Reviews 104, 6017 (2004). 
2P. Calvo, C. RemunanLopez, J. L. VilaJato, and M. J. Alonso, Journal of Applied 
Polymer Science 63, 125 (1997). 
3N. Boucard, C. Viton, D. Agay, E. Mari, T. Roger, Y. Chancerelle, and A. Domard, 
Biomaterials 28, 3478 (2007). 
4I. M. Helander, E. L. Nurmiaho-Lassila, R. Ahvenainen, J. Rhoades, and S. Roller, 
International Journal of Food Microbiology 71, 235 (2001). 
5J. K. F. Suh and H. W. T. Matthew, Biomaterials 21, 2589 (2000). 
6K. Roy, H. Q. Mao, S. K. Huang, and K. W. Leong, Nature Medicine 5, 387 (1999). 
7S. Yang, S. Chang, K. Tsai, W. Chen, F. Lin, and M. Shieh, Journal of Gene Medicine 
12, 168 (2010). 
8M. T. Taghizadeh and R. Abdollahi, Ultrasonics Sonochemistry 18, 149 (2011). 
9D. Kane, W. Grassi, R. Sturrock, and P. V. Balint, Rheumatology 43, 931 (2004). 
10Maeda T, Masaki C, Kanao M, Kondo Y, Ohta A, Nakamoto T, and H. R, Journal of 
Prosthodontic Research 57, 93 (2013). 
11F. Wu, W. Z. Chen, J. Bai, J. Z. Zou, Z. L. Wang, H. Zhu, and Z. B. Wang, Ultrasound 
in Medicine and Biology 27, 1099 (2001). 
12H. Hosseinkhani, T. Aoyama, O. Ogawa, and Y. Tabata, Current pharmaceutical 
biotechnology 4, 109 (2003). 
 12
13L. R. Duarte, Archives of Orthopaedic and Trauma Surgery 101, 153 (1983). 
14B. P. Timko, T. Dvir, and D. S. Kohane, Advanced Materials 22, 4925 (2010). 
15M. E. Johnson, S. Mitragotri, A. Patel, D. Blankschtein, and R. Langer, Journal of 
Pharmaceutical Sciences 85, 670 (1996). 
16W. G. Pitt, G. A. Husseini, and B. J. Staples, Expert opinion on drug delivery 1, 37 
(2004). 
17N. Y. Rapoport, J. N. Herron, W. G. Pitt, and L. Pitina, Journal of Controlled Release 
58, 153 (1999). 
18Z. Zhang, K. Xu, Y. Bi, G. Yu, S. Wang, X. Qi, and H. Zhong, Plos One 8 (2013). 
19C. Arthur, T. Flaig, L. J. Su, R. Denney, F. Barnes, and L. M. Glode, Ultrasonics 46, 68 
(2007). 
20M. A. Hassan, Y. Furusawa, M. Minemura, N. Rapoport, T. Sugiyama, and T. Kondo, 
Plos One 7 (2012). 
21B. A. Chen, Y. Y. Dai, X. M. Wang, R. Y. Zhang, W. L. Xu, H. L. Shen, F. Gao, Q. 
Sun, X. J. Deng, J. H. Ding, C. Gao, Y. Y. Sun, J. Cheng, J. Wang, G. Zhao, and N. N. 
Chen, International Journal of Nanomedicine 3, 343 (2008). 
22X. M. Wang, R. Y. Zhang, C. H. Wu, Y. Y. Dai, M. Song, S. Gutmann, F. Gao, G. Lv, 
J. Y. Li, X. M. Li, Z. Q. Guan, D. G. Fu, and B. A. Chen, Journal of Biomedical 
Materials Research Part A 80A, 852 (2007). 
23L. F. Qi, Z. R. Xu, X. Jiang, C. H. Hu, and X. F. Zou, Carbohydrate Research 339, 2693 
(2004). 
 13
24M. Huang, E. Khor, and L. Y. Lim, Pharmaceutical Research 21, 344 (2004). 
25M. Huang, Z. S. Ma, E. Khor, and L. Y. Lim, Pharmaceutical Research 19, 1488 
(2002). 
 14
Figure Captions 
Figure 1. Schematic of experimental setup.  
Figure 2. Fluorescence micrographs showing FITC-labeled chitosan nanoparticles 
(visualized in the green channel) after being internalized by MC3T3-E1 preosteoblasts 
(nuclei visualized in the blue channel). Cells were exposed to nanoparticles in the 
absence (a,b) or presence (c-f) of ultrasound and incubated for a total of 30 minutes (a) or 
120 minutes (b-f). Ultrasound was applied at 1 W/cm2 for 30 s (c) or 60 s (d), and at 2 
W/cm2 for 30 s (e) or 60 s (f). Images are representative of two independent experiments. 
Scale, 25 µm.  
 
Figure 3. Effect of ultrasound on viability of MC3T3-E1 cells 24 hours after CNP 
delivery and US stimulation. All values were expressed as mean±SE, **p<0.01, 
***p<0.001 (n=3).  
 
Figure 4. Scatter (a-d) and contour (e-h) plots of flow cytometry data for untreated cells 
(a,e), cells exposed only to 2 W/cm2 US for 60 s (b,f), cells exposed only to chitosan 
nanoparticles (c,g), and cells exposed both to chitosan nanoparticles and 2 W/cm2 US for 
60 s (d,h). Fluorescence intensities of propidium iodide (PI) and FITC are displayed on 
the x- and y-axes, respectively.  
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